- Home
- PDSB vs VRCA Comparison
PDSB vs VRCA Comparison
Compare PDSB & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- VRCA
- Stock Information
- Founded
- PDSB 2005
- VRCA 2013
- Country
- PDSB United States
- VRCA United States
- Employees
- PDSB N/A
- VRCA N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- PDSB Health Care
- VRCA Health Care
- Exchange
- PDSB Nasdaq
- VRCA Nasdaq
- Market Cap
- PDSB 58.7M
- VRCA 58.0M
- IPO Year
- PDSB N/A
- VRCA 2018
- Fundamental
- Price
- PDSB $0.96
- VRCA $0.45
- Analyst Decision
- PDSB Strong Buy
- VRCA Hold
- Analyst Count
- PDSB 3
- VRCA 5
- Target Price
- PDSB $10.00
- VRCA $6.00
- AVG Volume (30 Days)
- PDSB 795.8K
- VRCA 545.9K
- Earning Date
- PDSB 05-14-2025
- VRCA 05-12-2025
- Dividend Yield
- PDSB N/A
- VRCA N/A
- EPS Growth
- PDSB N/A
- VRCA N/A
- EPS
- PDSB N/A
- VRCA N/A
- Revenue
- PDSB N/A
- VRCA $7,566,000.00
- Revenue This Year
- PDSB N/A
- VRCA $118.94
- Revenue Next Year
- PDSB N/A
- VRCA $94.35
- P/E Ratio
- PDSB N/A
- VRCA N/A
- Revenue Growth
- PDSB N/A
- VRCA 47.66
- 52 Week Low
- PDSB $1.05
- VRCA $0.39
- 52 Week High
- PDSB $4.42
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- PDSB 32.49
- VRCA 31.84
- Support Level
- PDSB $1.19
- VRCA $0.38
- Resistance Level
- PDSB $1.41
- VRCA $0.45
- Average True Range (ATR)
- PDSB 0.10
- VRCA 0.06
- MACD
- PDSB -0.03
- VRCA -0.01
- Stochastic Oscillator
- PDSB 2.11
- VRCA 13.93
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.